Company: THS
Filing Date: 2025-11-10
Form Type: 10-Q
Source: 0001320695-25-000107
Chunk: 55

Company: TreeHouse Foods, Inc.
Filing Date: 2025-11-10
Form: 10-Q
Item: Part I, Item 1
Chunk 55
---
, and $393.5 million remained available under the $400 million total authorization of the stock repurchase program as of September 30, 2025. Any shares repurchased will be held as treasury stock.The following table summarizes the Company's repurchases of its common stock:Three Months EndedSeptember 30,Nine Months EndedSeptember 30,2025202420252024(In millions, except per share data)Shares repurchased— — — 2.5 Weighted average price per share$— $— $— $36.20 Total cost$— $— $— $88.7 Excise tax (1)$— $— $— $0.8 (1)The excise tax accrued in connection with the share repurchases was recorded as an adjustment to the cost basis of repurchased shares in treasury stock and within Accrued expenses on the Company’s Condensed Consolidated Balance Sheets.

20

TREEHOUSE FOODS, INC.NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

12. EARNINGS PER SHARE The weighted average number of common shares used in the diluted loss per share calculation is determined using the treasury stock method and includes the incremental effect related to the Company’s outstanding stock-based compensation awards. The following table summarizes the effect of the share-based compensation awards on the weighted average number of shares outstanding used in calculating diluted loss per share: Three Months EndedSeptember 30,Nine Months EndedSeptember 30,2025202420252024(In millions)Weighted average common shares outstanding50.5 51.9 50.5 52.7 Assumed exercise/vesting of equity awards (1)— — — — Weighted average diluted common shares outstanding50.5 51.9 50.5 52.7  (1)For all periods presented, the weighted average common shares outstanding is the same for the computations of both basic and diluted shares outstanding because the Company had a net loss for the period. Equity awards, excluded from our computation of diluted earnings per share because they were anti-dilutive, were 1.3 million and 0.5 million for the three months ended September 30, 2025 and 2024, respectively, and 1.3 million and 0.6 million for the nine months ended September 30, 2025